SCHEMBL31308548

SCHEMBL31308548

O=c1c(-c2ccccc2F)coc2ccc(Br)cc12

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GABRP O00591 1/20 0.57
▸ GABRD O14764 1/20 0.57
▸ GABRA1 P14867 1/20 0.57
▸ GABRB1 P18505 1/20 0.57
▸ GABRG2 P18507 1/20 0.57
▸ GABRB3 P28472 1/20 0.57
▸ GABRA5 P31644 1/20 0.57
▸ GABRA3 P34903 1/20 0.57
▸ GABRA2 P47869 1/20 0.57
▸ GABRB2 P47870 1/20 0.57
▸ GABRA4 P48169 1/20 0.57
▸ GABRE P78334 1/20 0.57
▸ GABRA6 Q16445 1/20 0.57
▸ GABRG1 Q8N1C3 1/20 0.57
▸ GABRG3 Q99928 1/20 0.57
▸ GABRQ Q9UN88 1/20 0.57
▸ MEN1 O00255 2/20 0.54
▸ MAPT P10636 2/20 0.54
▸ KMT2A Q03164 2/20 0.54
▸ SMN1; SMN2 Q16637 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27839334 0.82 SMN1; SMN2 (0.67) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL28990318 0.81 PTPN1 (0.61) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL13267885 0.81 NMUR2 (0.55) MAPTSMN1; SMN2PTPN1NMUR2MAOB
SCHEMBL9066 0.75 GABRP (0.59) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL5266878 0.73 ALOX12 (0.48) MEN1KMT2ASMN1; SMN2PTPN1NMUR2
SCHEMBL8047 0.73 GABRP (0.56) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL8679 0.72 GABRP (0.55) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL17522053 0.72 PTPN1 (0.58) MEN1MAPTKMT2ASMN1; SMN2PTPN1
SCHEMBL8308 0.71 GABRA1 (0.54) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL8307 0.71 GABRP (0.54) GABRPGABRDGABRA1GABRB1GABRG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240360095-A1 NOVEL KINASE MODULATORS RHIZEN PHARMACEUTICALS AG (CH) 2024-10-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240360095-A1 NOVEL KINASE MODULATORS PRKCA, PRKCH, PRKCB GABRP 1342/4885GABRD 2739/4885GABRA1 3106/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback